Research programme: dual aurora kinase/VEGFR2 inhibitors - TelikAlternative Names: A 60; EA 19; TLK 60404
Latest Information Update: 17 Apr 2013
At a glance
- Originator Telik
- Class Small molecules
- Mechanism of Action Aurora kinase inhibitors; Vascular endothelial growth factor receptor-2 antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer